仅适用于腹部的压缩服可以减少静止心动节拍和改善姿势静止心动节拍综合征患者的症状
Kate M Bourne1, Kavithra Karalasingham2, Tanya Siddiqui2
1Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: https://x.com/katebournebsc.
The Canadian journal of cardiology
|December 3, 2025
概括
腹部压缩服有效地降低了心率,改善了姿势正静性心力衰竭综合征 (POTS) 患者的症状. 这些服装为POTS症状管理提供了一种实用,易于使用的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生理学 生理学 生理学
背景情况:
- 姿势正静性心拍综合征 (POTS) 是一种影响自主神经系统调节的疾病.
- 腹部压缩服是一种低成本,易于使用的干预措施,但它们在POTS中的实际有效性尚未得到充分证实.
- 这项研究研究了商用腹部压缩服在POTS患者的有效性.
研究的目的:
- 评估腹部压缩服对POTS患者心率 (HR) 和症状的影响.
- 评估腹部压缩在现实环境中的急性和持续的影响.
主要方法:
- 进行了四次10分钟的活跃站式测试:早上没有 (AM-OFF) 和 (AM-ON) 服装,下午有 (PM-ON) 和没有 (PM-OFF) 服装.
- 参与者使用药物来可能增加HR和血压.
- 霍尔特监视器记录了HR,而范德比尔特正统症状评分评估了症状 (0-90级).
主要成果:
- 在早晨测试 (AM-ON vs. AM-OFF) 中腹部压缩显著降低了站立HR和HR从仰卧变化,并改善了症状.
- 当服装在几个小时后被取下来时 (PM-ON vs. PM-OFF),站立HR,HR变化和症状得分增加,表明持续的好处.
- 在所有主要结果指标中观察到统计学意义 (P < 0.05).
结论:
- 商用腹部压缩服在减少HR和改善POTS患者症状方面提供了急性和持续的好处.
- 腹部压缩服是一种可行的和潜在的可取替代品,可以替代整个腰部高压缩服来管理POTS.
- 这些发现支持使用腹部压缩作为POTS的实用,非药物治疗策略.
相关概念视频
Increased pulse rate
1.1K
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.1K
Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
Aortic Regurgitation IV: Nursing Management
262
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
262
Decreased pulse rate
824
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
824
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
326
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
326
Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374


